1-(tert-Butoxycarbonyl)-3-methylazetidine-3-carboxylic acid, 95.0%, 250mg

(R)-1-(2-Methyl-3-(trifluoromethyl)phenyl)ethan-1-amine hydrochloride, 98%, 250mg

2-(3-Methylphenyl)propan-2-amine, 97%, 1g

Methyl 2-amino-4-(2-methoxy-2-oxoethyl)thiazole-5-carboxylate hydrochloride, 97.0%, 1g

2,3-Dihydro-1H-pyrrolo[2,3-c]pyridine, 95.0%, 5g

Sodium 3-nitrobenzenesulfonate, 98+%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methyl-3-(tritylthio)butanoic acid, 97%, 5g

2,3-Diphenylquinoxaline, 98.0%, 100g

N1-(4-Chlorobenzyl)-N2,N2-dimethyl-N1-(pyridin-2-yl)ethane-1,2-diamine hydrochloride, 95.0%, 25mg

Indium AAS standard solution, ROTI®Star, 100 ml, HDPE

1-Aminocyclobutanecarboxylic acid, 97.0%, 10g

DL-Phenylephrine Hydrochloride>98.0%(HPLC)(T)25g

Secoisolariciresinol Diglucoside>98.0%(HPLC)25mg